ATI RN
ATI Pharmacology Proctored Questions
Question 1 of 5
Which of the following conditions is not treated with Lansoprazole?
Correct Answer: C
Rationale: Rationale: Lansoprazole is a proton pump inhibitor used to reduce stomach acid production. Hypertension is a condition related to high blood pressure and is not treated with Lansoprazole. Zollinger-Ellison syndrome, gastritis, and reflux are all conditions that can be treated with Lansoprazole due to its ability to reduce stomach acid. Therefore, choice C is the correct answer.
Question 2 of 5
What is the antidote for copper toxicity?
Correct Answer: D
Rationale: The correct answer is D: Penicillamine. Penicillamine is a chelating agent that binds to copper and forms a complex that can be excreted from the body, making it an effective antidote for copper toxicity. Glucagon (A) is used for treating hypoglycemia, aminocaproic acid (B) is used to treat excessive bleeding, and atropine (C) is used to treat bradycardia and organophosphate poisoning, none of which are related to copper toxicity.
Question 3 of 5
Which of the following is the antidote for benzodiazepine toxicity?
Correct Answer: A
Rationale: The correct answer is A: Flumazenil. Flumazenil is a specific benzodiazepine receptor antagonist that can reverse the effects of benzodiazepine toxicity by competitively inhibiting the binding of benzodiazepines to their receptors. It works by reversing the sedative and respiratory depressant effects of benzodiazepines. Methylene blue (B) is used to treat methemoglobinemia, not benzodiazepine toxicity. Deferoxamine (C) is used for iron toxicity. Alkalinizing urine (D) is used to enhance the excretion of weak acids in the urine, not for benzodiazepine toxicity.
Question 4 of 5
Which of the following is the antidote for lead poisoning?
Correct Answer: C
Rationale: The correct answer is C: CaEDTA. Calcium disodium ethylenediaminetetraacetic acid (CaEDTA) is a chelating agent used to treat lead poisoning by binding to lead ions in the bloodstream and enhancing their excretion through urine. It forms stable complexes with lead, reducing its toxicity. Naloxone (A) is an opioid receptor antagonist, used to reverse opioid overdose. Nitrite (B) is used in cyanide poisoning. Dialysis (D) is not effective in removing lead from the body as lead is not effectively dialyzable.
Question 5 of 5
Which of the following is the primary site of activity for the drug Warfarin?
Correct Answer: B
Rationale: The correct answer is B: Liver. Warfarin is primarily metabolized in the liver by the cytochrome P450 enzyme system. The liver is responsible for breaking down and activating many drugs, including Warfarin. It is where the drug's metabolism and effects are most significant. The other choices are incorrect because Warfarin's main site of activity is in the liver, not the kidney, blood, or heart. The kidney mainly excretes the drug, while the blood carries it throughout the body, and the heart is not directly involved in Warfarin's metabolism.